Apria, Inc.
Customers
2
2 disclosed
Suppliers
0
None disclosed
Largest customer
21%
Medicare · FY to 2021-12-31
Named-customer revenue
$252.0M
2 customers · FY to 2021-12-31
Latest period
Dec 31, 2021
10-K filed 2022-03-01
Customers 2
Companies Apria, Inc. discloses as major customers, as a share of Apria, Inc. revenue. 2 active, 0 lapsed.
| Company | % of Apria, Inc. revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| Medicare Non-SEC Medicare |
21% | $240.5M | FY 2021-12-31 | −1.0pp | Active | 10-K 2022-03-01 |
For the year ended December 31, 2021, approximately 21% of our revenue was from servicing patients with traditional Medicare coverage. Contracts with a single national payor constituted 86% of total capitation revenues in the three and nine months ended September 30, 2021 and 2020.Concentration of Credit Risk—Revenues reimbursed under arrangements with Medicare and Medicaid were approximately 22% and 1%, respectively, of total net revenues for the three months ended September 30, 2021 and 21% and 1%, respectively, of total net revenues for the nine months ended September 30, 2021. Contracts with a single national payor constituted 86% of total capitation revenues in the three months ended June 30, 2021 and 2020, and 86% of the total capitation revenues for the six months ended June 30, 2021 and 2020.Concentration of Credit Risk—Revenues reimbursed under arrangements with Medicare and Medicaid were approximately 21% and 1%, respectively, of total net revenues for the three and six months ended June 30, 2021. Contracts with a single national payor constituted 86% of the total capitation revenues in each of the three months ended March31, 2021 and 2020.Concentration of Credit Risk—Revenues reimbursed under arrangements with Medicare and Medicaid were approximately 21% and 1%, respectively, of total net revenues for the three months ended March 31, 2021. | ||||||
| Medicaid Non-SEC Medicaid |
1% | $11.5M | FY 2021-12-31 | ±0.0pp | Active | 10-K 2022-03-01 |
For the year ended December 31, 2021, approximately 21% and 1% of our net revenues were reimbursed under arrangements with Medicare and state Medicaid programs, respectively. Contracts with a single national payor constituted 86% of total capitation revenues in the three and nine months ended September 30, 2021 and 2020.Concentration of Credit Risk—Revenues reimbursed under arrangements with Medicare and Medicaid were approximately 22% and 1%, respectively, of total net revenues for the three months ended September 30, 2021 and 21% and 1%, respectively, of total net revenues for the nine months ended September 30, 2021. Contracts with a single national payor constituted 86% of total capitation revenues in the three months ended June 30, 2021 and 2020, and 86% of the total capitation revenues for the six months ended June 30, 2021 and 2020.Concentration of Credit Risk—Revenues reimbursed under arrangements with Medicare and Medicaid were approximately 21% and 1%, respectively, of total net revenues for the three and six months ended June 30, 2021. Contracts with a single national payor constituted 86% of the total capitation revenues in each of the three months ended March31, 2021 and 2020.Concentration of Credit Risk—Revenues reimbursed under arrangements with Medicare and Medicaid were approximately 21% and 1%, respectively, of total net revenues for the three months ended March 31, 2021. | ||||||
Alerts are coming
Get an email when Apria, Inc.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.